Serum parameters after traumatic brain injury

被引:0
作者
Wanke-Jellinek, L. [2 ]
Biberthaler, P. [1 ]
机构
[1] Tech Univ Munich, Klin & Poliklin Unfallchirurg, Ismaningerstr 22, D-81675 Munich, Germany
[2] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA
关键词
Craniocerebral trauma; Glasgow Coma Scale; Serum markers; Biomarkers; S100B protein;
D O I
10.1007/s10039-013-1957-2
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Classification. In patients with traumatic brain injury (TBI), the Glasgow Coma Scale (GCS) is the most commonly used system for classification of TBI severity. Using the GCS score TBI can be classified into mild (GCS 1513), moderate (GCS 13-9) and severe (GCS 8-3). Diagnostics. In patients with moderate or severe TBI cranial computed tomography (CCT) is obligatory. In patients presenting with mild TBI physicians face a dilemma because the neurological impairment occurs more often as a corollary of acute intoxication or pre-existing conditions and not due to intracranial lesions. Nevertheless, to exclude the risk of intracranial bleeding all patients with mild TBI have to undergo neuroradiological imaging. Individuals suffering from mild TBI would therefore benefit from additional evaluation of serum parameters that help to determine the necessity for a CCT scan. Literature. This review provides a critical assessment of current serum parameters used for the diagnosis of mild TBI and the current state of knowledge.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 72 条
[1]  
Balakathiresan, N., Bhomia, M., Chandran, R., MicroRNA let-7i is a promising serum biomarker for blast-induced traumatic brain injury (2012) J Neurotrauma, 29 (7), pp. 1379-1387
[2]  
Bazarian, J.J., Zemlan, F.P., Mookerjee, S., Stigbrand, T., Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury (2006) Brain Inj, 20, pp. 759-765
[3]  
Bazarian, J.J., Zhong, J., Blyth, B., Diffusion tensor imaging detects clinically important axonal damage after mild traumatic brain injury: A pilot study (2007) J Neurotrauma, 24, pp. 1447-1459
[4]  
Begaz, T., Kyriacou, D.N., Segal, J., Bazarian, J.J., Serum biochemical markers for post-concussion syndrome in patients with mild traumatic brain injury (2006) J Neurotrauma, 23, pp. 1201-1210
[5]  
Berger, R.P., Bazaco, M.C., Wagner, A.K., Trajectory analysis of serum biomarker concentrations facilitates outcome prediction after pediatric traumatic and hypoxemic brain injury (2010) Dev Neurosci, 32, pp. 396-405
[6]  
Berger, R.P., Hayes, R.L., Richichi, R., Serum concentrations of ubiquitin C-terminal hydrolase-L1 and aII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI (2012) J Neurotrauma, 29 (1), pp. 162-167
[7]  
Biberthaler, P., Mussack, T., Kanz, K.G., Identifikation von Hochrisikopatienten nach leichtem Schädel-Hirn- Trauma Messung des neuroglialen Proteins S100 (2004) Unfallchirurg, 107 (3), pp. 197-202
[8]  
Biberthaler, P., Linsenmeier, U., Pfeifer, K., Serum S-100B concentration provides additional information for the indication of computed tomography in patients after minor head injury: A prospective multicenter study (2006) Shock, 25 (5), pp. 446-453
[9]  
Blyth, B.J., Farahvar, A., He, H., Elevated serum ubiquitin carboxy-terminal hydrolase L1 is associated with abnormal bloodbrain barrier function after traumatic brain injury (2011) J Neurotrauma, 28, pp. 2453-2462
[10]  
Büki, A., Okonkwo, D.O., Wang, K.K., Povlishock, J.T., Cytochrome C release and caspase activation in traumatic axonal injury (2000) J Neurosci, 20 (8), pp. 2825-2834